Patents

Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs

The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatotoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutically acceptable additives and method of treating drug induced hepatotoxicity.

Filing Date: 27-03-2002

Issue Date: 21-02-2006

Patent No: US7001619 [USA]

Application No: 106119

Inventor(s): Johri, Rakesh Kamal; Abdullah, Sheikh Tasaduq; Singh, Kuldeep; Gupta, Devinder Kumar; Kapahi, Bal Krishan; Mondhe, Dilip Manikrao; Jain, Satinder Mohan; Suri, Om Parkash; Bedi, Kasturi Lal; Qazi, Ghulam Nabi

Licensing Option: Laboratory willing to jointly develop technology with industrial partner.

Implementing institute: CSIR-Indian Institute of Integrative Medicine [CSIR-IIIM]

Funding agency: Council of Scientific and Industrial Research (CSIR)

IPC Classification: A61K9/00, A61K9/20, A61K 35/00, A61K 35/78

Related Patents

Calcium silicate hydrate anion exchange membrane useful for water electrolysis and fuel cells and a process for the preparation thereof
CH2501706: Synthesis Of Novel 3-Substituted (7-Imino-2-Thioxo-3,7-Dihydro-2h-Thiazolo 4,5-D] Pyrimidin-6-Yl)-Urea And Furan-2-Carboxylic Acid (7-Imino-2-Thioxo-3,7-Dihydro-2h-Thiazolo [4,5-D] Pyrimidin-6-Yl)-Amide As Potential Adenosine A2a Receptor Antagonists
CN108697808: Protein nanostructures for the delivery of therapeutic agents to the anterior segment of the eye
CN200380110308: A novel process for biobleaching of kraft pulp using defined bacterial consortia
DE10394224: A process for the separation and recovery of polyethylene glycol (peg) spent aqueous two-phase system